CardiOvascular Risk and idEntificAtion of Potential High-risk Population in Acute Myocardial Infarction II (COREA-AMI II)

• Status: Unknown status
• Trial end date: 2018-02-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is intended to provide contemporary data on the residual cardiovascular risk in all consecutive patients with acute myocardial infarction, especially in patients who survived stably within one-year after percutaneous coronary intervention.

In addition, this study will identify which baseline clinical, angiographic, or treatment factors are associated with residual cardiovascular risk and bleeding events

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul St. Mary's Hospital
• Collaborators: AstraZeneca; Chonnam National University; The Catholic University of Korea

Criteria

Inclusion Criteria:

• Acute myocardial infarction who were treated with percutaneous coronary intervention using stents

Exclusion Criteria:

• Acute myocardial infarction who were treated with only balloon angioplasty

• Acute myocardial infarction who were managed by conservative strategy